Trump Admin to Officially Revoke California’s Waiver to Set Stricter Emissions Standards
Revoking California's waiver is part of a broader effort to roll back Obama-era fuel efficiency standards for cars and light trucks. In a draft proposal released in August of 2018, the administration had promised to replace the Obama-era requirement that cars average 54.5 miles per gallon by 2025 with a much less ambitious target of around 37 miles per gallon. It also said it would revoke California's ability to set its own standards, so that automakers would not have to build for two national markets.
But the reduced standards, which would allow nearly six billion tons of carbon dioxide pollution to enter the atmosphere, have been delayed as staff work to justify them scientifically, legally and technically, The New York Times explained. So the administration decided to move forward with revoking California's waiver.
"Trump has married his administration-wide hostility to the environment to his personal vendetta against California," Safe Climate Campaign Director Dan Becker told The New York Times.
President Trump’s attack on California and other states threatens to make America polluted again. It rejects cleaner, less-polluting vehicles in favor of pollution-spewing Trump-mobiles for urban cowboys hauling lattes home from Starbucks. #cleanercarshttps://t.co/cZtxFzXQ7l pic.twitter.com/Aj9D0gZvsQ— Safe Climate Campaign (@safe_climate) September 17, 2019
The move is likely to set off a legal battle that could go all the way to the Supreme Court. Part of the reason that the administration moved forward with revoking the waiver is so that it would have a chance to defend the decision in the nation's highest court before a potential election loss in 2020. The New York Times explained the stakes of that potential fight:
Legal experts said that if Mr. Trump's move was ultimately held up by the Supreme Court, it could permanently block states from regulating vehicle greenhouse gas pollution. If it was rejected by the Supreme Court, it would allow states to set separate tailpipe pollution standards from those set by the federal government.
The outcome could split the United States auto market, with some states adhering to stricter pollution standards than others. For automakers, that would be a nightmare.
Thirteen states, representing one third of the U.S. auto market, currently follow California's standards.
For its part, California intends to fight.
"While the White House has abdicated its responsibility to the rest of the world on cutting emissions and fighting global warming, California has stepped up," Gov. Gavin Newsom told The Washington Post. "It's a move that could have devastating consequences for our kids' health and the air we breathe, if California were to roll over. But we will not."
Hi, @realDonaldTrump. Let me break it down in simple terms for you...— Gavin Newsom (@GavinNewsom) September 17, 2019
-Protects our air & health
-Is good for the economy
-Allows families to pay less at the pump
We’re here in the 21st century. Let us know when you decide to join us. https://t.co/gZzUjXeFxo
The administration was scheduled to announce the new policy Wednesday, but delayed the announcement by at least one day after the news broke Tuesday, The Washington Post reported.
"In the very near future, the Trump administration will begin taking the steps necessary to establish one set of national fuel-economy standards," Wheeler said, as POLITICO reported. "We embrace federalism and the role of the states, but federalism does not mean that one state can dictate standards for the nation," Wheeler continued.
The revoked waiver was also partly retaliation for a deal California struck with four automakers this summer. Ford, Honda, Volkswagen and BMW of North America agreed to emissions standards of 51 miles per gallon by 2026. The EPA and Transport Department criticized the move, and the Justice Department launched an anti-trust investigation into the deal, POLITICO reported.
"It's clear that the president felt very strongly about this," Thomas J. Pyle, president of pro-fossil fuel think tank the Institute for Energy Research, told The New York Times. "The actions of California and the other auto companies probably firmed up or hardened the president's resolve on this issue, so here we go."
But environmental experts pointed out that the battle between California and the Trump administration could have global consequences.
Obama-era EPA air official Janet McCabe told POLITICO that climate change "is a 'y'all come' situation, where we need all the reasonable programs that we can get in place. And this is one of the most reasonable and impactful across the board," she said.
EcoWatch Daily Newsletter
Jane Goodall on Conservation, Climate Change and COVID-19: 'If We Carry on With Business as Usual, We're Going to Destroy Ourselves'
By Jeff Berardelli
While COVID-19 and protests for racial justice command the world's collective attention, ecological destruction, species extinction and climate change continue unabated. While the world's been focused on other crises, an alarming study was released warning that species extinction is now progressing so fast that the consequences of "biological annihilation" may soon be "unimaginable."
- Jane Goodall Institute Revolutionizes Chimpanzee Protection With ... ›
- These Jane Goodall Quotes Will Inspire You to Save the World ... ›
- Jane Goodall: COVID-19 Is Result of Our Unhealthy Relationship ... ›
Anyone entering a U.S. Starbucks from July 15 will have to wear a face mask, the company announced Thursday.
- 3 Ways to Go Plastic-Free This July While Staying Safe From ... ›
- Starbucks Is Testing Fully Compostable Cups in Five Cities ... ›
- Reusable Cups, Bags and Containers Can Be Safe During COVID ... ›
- Starbucks Becomes Largest Food and Beverage Retailer to ... ›
On Monday and Tuesday of the week that President Donald Trump held his first rally since March in Tulsa, Oklahoma, the county reported 76 and 96 new coronavirus cases respectively, according to POLITICO. This week, the county broke its new case record Monday with 261 cases and reported a further 206 cases on Tuesday. Now, Tulsa's top public health official thinks the rally and counterprotest "likely contributed" to the surge.
- No Social Distancing or Mask Requirement at Trump's Mt ... ›
- Trump Plans to End Federal Funding for COVID-19 Testing Sites ... ›
- Attendees at Trump's First Rally Since March Can't Sue if They Get ... ›
Rainforests are an important defense against climate change because they absorb carbon. But many are being destroyed on a massive scale.
- Brazil's Amazon Rainforest Is the Wild West for Illegal Gold Miners ... ›
- Trump Moves to Open 16.7 Million Acre Alaskan Rainforest to ... ›
- Amazon Rainforest Reaches Point of No Return - EcoWatch ›
As we look for advanced technology to replace our dependence on fossil fuels and to rid the oceans of plastic, one solution to the climate crisis might simply be found in rocks. New research found that dispersing rock dust over farmland could suck billions of tons of carbon dioxide from the air every year, according to the first detailed large scale analysis of the technique, as The Guardian reported.
- California Startup Opus 12 Recycles Carbon Dioxide - EcoWatch ›
- UK Biomass Plant Starts Groundbreaking Carbon Capture Project ... ›
- 8 Ways to Sequester Carbon to Avoid Climate Catastrophe - EcoWatch ›
By Tim Radford
German scientists now know why so many fish are so vulnerable to ever-warming oceans. Global heating imposes a harsh cost at the most critical time of all: the moment of spawning.
Nearing the Brink<p>Since <a href="https://climatenewsnetwork.net/abundant-fish-need-cool-seas-and-protection/" target="_blank">fish in the temperate zones already experience a wide variation</a> in seasonal water temperatures, it hasn't been obvious why species such as <a href="https://climatenewsnetwork.net/sardines-swim-into-northern-waters-to-keep-cool/" target="_blank">cod have shifted nearer the Arctic, and sardines have migrated to the North Sea</a>.</p><p>But <a href="https://climatenewsnetwork.net/ocean-warming-spurs-marine-life-to-rapid-migration/" target="_blank">marine creatures are on the move</a>, and although there are other factors at work, including overfishing and <a href="https://climatenewsnetwork.net/fish-cant-smell-well-in-more-acidic-seas/" target="_blank">the increasingly alarming changes in ocean chemistry</a>, thanks to ever-higher levels of dissolved carbon dioxide, temperature change is part of the problem.</p><p>The latest answer, Dr Dahlke and his colleagues report in the journal <a href="https://science.sciencemag.org/cgi/doi/10.1126/science.aaz3658" target="_blank">Science</a>, is that many fish may already be living near the limits of their thermal tolerance.</p><p>The temperature safety margins during the moments of spawning and embryo might be very precise, and over hundreds of thousands of years of evolution, marine and freshwater species have worked out just what is best for the next generation. Rapid global warming upsets this equilibrium.</p>
By Sherry H-Y. Chou, Aarti Sarwal and Neha S. Dangayach
The patient in the case report (let's call him Tom) was 54 and in good health. For two days in May, he felt unwell and was too weak to get out of bed. When his family finally brought him to the hospital, doctors found that he had a fever and signs of a severe infection, or sepsis. He tested positive for SARS-CoV-2, the virus that causes COVID-19 infection. In addition to symptoms of COVID-19, he was also too weak to move his legs.
When a neurologist examined him, Tom was diagnosed with Guillain-Barre Syndrome, an autoimmune disease that causes abnormal sensation and weakness due to delays in sending signals through the nerves. Usually reversible, in severe cases it can cause prolonged paralysis involving breathing muscles, require ventilator support and sometimes leave permanent neurological deficits. Early recognition by expert neurologists is key to proper treatment.
We are neurologists specializing in intensive care and leading studies related to neurological complications from COVID-19. Given the occurrence of Guillain-Barre Syndrome in prior pandemics with other corona viruses like SARS and MERS, we are investigating a possible link between Guillain-Barre Syndrome and COVID-19 and tracking published reports to see if there is any link between Guillain-Barre Syndrome and COVID-19.
Some patients may not seek timely medical care for neurological symptoms like prolonged headache, vision loss and new muscle weakness due to fear of getting exposed to virus in the emergency setting. People need to know that medical facilities have taken full precautions to protect patients. Seeking timely medical evaluation for neurological symptoms can help treat many of these diseases.
What Is Guillain-Barre Syndrome?
Guillain-Barre syndrome occurs when the body's own immune system attacks and injures the nerves outside of the spinal cord or brain – the peripheral nervous system. Most commonly, the injury involves the protective sheath, or myelin, that wraps nerves and is essential to nerve function.
Without the myelin sheath, signals that go through a nerve are slowed or lost, which causes the nerve to malfunction.
To diagnose Guillain-Barre Syndrome, neurologists perform a detailed neurological exam. Due to the nerve injury, patients often may have loss of reflexes on examination. Doctors often need to perform a lumbar puncture, otherwise known as spinal tap, to sample spinal fluid and look for signs of inflammation and abnormal antibodies.
Studies have shown that giving patients an infusion of antibodies derived from donated blood or plasma exchange – a process that cleans patients' blood of harmful antibodies - can speed up recovery. A very small subset of patients may need these therapies long-term.
The majority of Guillain-Barre Syndrome patients improve within a few weeks and eventually can make a full recovery. However, some patients with Guillain-Barre Syndrome have lingering symptoms including weakness and abnormal sensations in arms and/or legs; rarely patients may be bedridden or disabled long-term.
Guillain-Barre Syndrome and Pandemics
As the COVID-19 pandemic sweeps across the globe, many neurologic specialists have been on the lookout for potentially serious nervous system complications such as Guillain-Barre Syndrome.
Though Guillain-Barre Syndrome is rare, it is well known to emerge following bacterial infections, such as Campylobacter jejuni, a common cause of food poisoning, and a multitude of viral infections including the flu virus, Zika virus and other coronaviruses.
Studies showed an increase in Guillain-Barre Syndrome cases following the 2009 H1N1 flu pandemic, suggesting a possible connection. The presumed cause for this link is that the body's own immune response to fight the infection turns on itself and attacks the peripheral nerves. This is called an "autoimmune" condition. When a pandemic affects as many people as our current COVID-19 crisis, even a rare complication can become a significant public health problem. That is especially true for one that causes neurological dysfunction where the recovery takes a long time and may be incomplete.
Though there is clear clinical suspicion that COVID-19 can lead to Guillain-Barre Syndrome, many important questions remain. What are the chances that someone gets Guillain-Barre Syndrome during or following a COVID-19 infection? Does Guillain-Barre Syndrome happen more often in those who have been infected with COVID-19 compared to other types of infections, such as the flu?
The only way to get answers is through a prospective study where doctors perform systematic surveillance and collect data on a large group of patients. There are ongoing large research consortia hard at work to figure out answers to these questions.
Understanding the Association Between COVID-19 and Guillain-Barre Syndrome
While large research studies are underway, overall it appears that Guillain-Barre Syndrome is a rare but serious phenomenon possibly linked to COVID-19. Given that more than 10.7 million cases have been reported for COVID-19, there have been 10 reported cases of COVID-19 patients with Guillain-Barre Syndrome so far – only two reported cases in the U.S., five in Italy, two cases in Iran and one from Wuhan, China.
It is certainly possible that there are other cases that have not been reported. The Global Consortium Study of Neurological Dysfunctions in COVID-19 is actively underway to find out how often neurological problems like Guillain-Barre Syndrome is seen in hospitalized COVID-19 patients. Also, just because Guillain-Barre Syndrome occurs in a patient diagnosed with COVID-19, that does not imply that it was caused by the virus; this still may be a coincident occurrence. More research is needed to understand how the two events are related.
Due to the pandemic and infection-containment considerations, diagnostic tests, such as a nerve conduction study that used to be routine for patients with suspected Guillain-Barre Syndrome, are more difficult to do. In both U.S. cases, the initial diagnosis and treatment were all based on clinical examination by a neurological experts rather than any tests. Both patients survived but with significant residual weakness at the time these case reports came out, but that is not uncommon for Guillain-Barre Syndrome patients. The road to recovery may sometimes be long, but many patients can make a full recovery with time.
Though the reported cases of Guillain-Barre Syndrome so far all have severe symptoms, this is not uncommon in a pandemic situation where the less sick patients may stay home and not present for medical care for fear of being exposed to the virus. This, plus the limited COVID-19 testing capability across the U.S., may skew our current detection of Guillain-Barre Syndrome cases toward the sicker patients who have to go to a hospital. In general, the majority of Guillain-Barre Syndrome patients do recover, given enough time. We do not yet know whether this is true for COVID-19-related cases at this stage of the pandemic. We and colleagues around the world are working around the clock to find answers to these critical questions.
Sherry H-Y. Chou is an Associate Professor of Critical Care Medicine, Neurology, and Neurosurgery, University of Pittsburgh.
Aarti Sarwal is an Associate Professor, Neurology, Wake Forest University.
Neha S. Dangayach is an Assistant Professor of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai.
Disclosure statement: Sherry H-Y. Chou receives funding from The University of Pittsburgh Clinical Translational Science Institute (CTSI), the National Institute of Health, and the University of Pittsburgh School of Medicine Dean's Faculty Advancement Award. Sherry H-Y. Chou is a member of Board of Directors for the Neurocritical Care Society. Neha S. Dangayach receives funding from the Bee Foundation, the Friedman Brain Institute, the Neurocritical Care Society, InCHIP-UConn Center for mHealth and Social Media Seed Grant. She is faculty for emcrit.org and for AiSinai. Aarti Sarwal does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Reposted with permission from The Conversation.